Arrowhead Pharmaceuticals, Inc. Earnings

Arrowhead Pharmaceuticals, Inc.’s revenue jumped +Inf% since last year same period to $542.71Mn in the Q1 2025. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated 21608.36% jump in its revenue since last 3-months.

Arrowhead Pharmaceuticals, Inc.’s net profit jumped 395.65% since last year same period to $370.45Mn in the Q1 2025. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated 314.02% jump in its net profits since last 3-months.

Arrowhead Pharmaceuticals, Inc.’s net profit margin jumped NaN% since last year same period to 68.26% in the Q1 2025. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated 100.99% jump in its net profit margins since last 3-months.

Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a 25.81% jump from last quarter’s estimates.

Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -0.64.

Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Arrowhead Pharmaceuticals, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.